Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice.

Int J Endocrinol · 2017 · PMC5376482 · PMID 28408925

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep = 0.1so close (0.05 < p ≤ 0.1)

Although ipragliflozin and alogliptin monotherapies tended to reduce atheromatous plaque volume in the aortic root, these changes did not reach statistical significance ( p = 0.1–0.2).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.